Lilia Stelmakh

Statistics

Publications

Citations

1.6K

H-Index

Active since

2010

Affiliations

First Pavlov State Medical University of St. Petersburg(Current)

Vilnius University

Roche (Switzerland)

Hospital Universitario Central de Asturias

Institute of Oncology Prof. Dr. Ion Chiricuta

Lilia Stelmakh is an author at First Pavlov State Medical University of St. Petersburg specializing in oncology, cancer pharmacology, and pharmacology.

Publications per year

2010–2020

Publications

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

Federico Cappuzzo, Tudor–Eliade Ciuleanu, Lilia Stelmakh et al. · The Lancet Oncology · 2010 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

Tudor–Eliade Ciuleanu, Lilia Stelmakh, Saulius Cicėnas et al. · The Lancet Oncology · 2012 · 373 citations

Medicine, Oncology, Pharmacology +13

A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma

Kirill V. Lepik, Liudmila Fedorova, Elena Kondakova et al. · HemaSphere · 2020 · 36 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–3 of 3